(Press-News.org) Bethesda, MD (Sept. 5, 2014) — Restarting infliximab therapy after a drug holiday is safe and effective for patients with inflammatory bowel disease (IBD), according to a new study1 in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.
"Our findings suggest that starting infliximab after a history of prior therapy can be very beneficial to patients," said lead study author Filip Baert, MD, PhD, from the department of gastroenterology, University Hospitals Leuven in Belgium. "Most striking, response to infliximab can be regained in a subset of patients who previously had lost response to the treatment and failed several other treatments thereafter."
Researchers conducted a retrospective single-center study to evaluate the efficacy of restarting infliximab in inflammatory bowel disease patients, both those suffering from Crohn's disease and ulcerative colitis. The average duration of infliximab holiday was 15 months.
Patients who were in remission at the time infliximab was discontinued were the best candidates, with a 78 percent response rate at one year. In patients with a previous loss of response or an infusion reaction, the strategy was effective in 45 percent of patients at one year; while less than the other group, this may be enough in cases where the patient has failed other treatment options.
This study shows that starting pharmacologic monitoring (i.e., checking levels of medicine in the blood and antibodies to infliximab) early after restarting infliximab can guide physicians to predict the long-term efficacy and safety of restarting this treatment. In clinical practice, these tests are not always readily available; however, measuring drug levels and antibodies early after restarting infliximab is very valuable and allows early optimization.
How safe is the strategy? Of the 128 patients re-treated, seven had severe infusion reactions, generally during the second or third induction dose. Unfortunately, premedication did not protect against all infusion reactions, but simultaneous immunomodulators did. Therefore, immunomodulator therapy should be strongly considered in these patients.
Patients may initially stop infliximab therapy due to loss of response, and, despite the current recommendations, patients sometimes will discontinue therapy for various reasons, including durable remission, pregnancy, safety or financial concerns.
"Clinicians understandably have been reluctant to rechallenge patients with infliximab given the fear of immediate or delayed hypersensitivity reactions with dose interruptions. This study provides the important message that restarting infliximab after a drug holiday is feasible," added Dr. Baert.
Infliximab was the first anti–tumor necrosis factor (TNF) biologic for Crohn's disease and still is used frequently for its efficacy in both Crohn's and ulcerative colitis. Studies have shown that loss of response to infliximab is about 13 percent per patient-year of treatment.
INFORMATION:
To learn more about IBD, review AGA's patient brochure.
About the AGA Institute
The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization.
About Clinical Gastroenterology and Hepatology
The mission of Clinical Gastroenterology and Hepatology is to provide readers with a broad spectrum of themes in clinical gastroenterology and hepatology. This monthly peer-reviewed journal includes original articles as well as scholarly reviews, with the goal that all articles published will be immediately relevant to the practice of gastroenterology and hepatology. For more information, visit http://www.cghjournal.org.
Like AGA and Clinical Gastroenterology and Hepatology on Facebook.
Join AGA on LinkedIn.
Follow us on Twitter @AmerGastroAssn.
Check out our videos on YouTube.
1 Baert, et al. Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy. Clinical Gastroenterology and Hepatology 2014: 12(9): 1474-1481.e2
IBD patients: Consider giving infliximab a second try
2014-09-05
ELSE PRESS RELEASES FROM THIS DATE:
New blood test could offer more tailored treatment of ovarian cancer
2014-09-05
A new blood test allowing doctors to predict which ovarian cancer patients will respond to particular types of treatment is a step closer following a new study by Manchester scientists.
Researchers from The University of Manchester and The Christie NHS Foundation Trust - both part of Manchester Cancer Research Centre - say the test could be developed and used in hospitals within the next few years.
It would mean medics could see which patients could benefit from blood vessel-targeting drugs - such as bevacizumab - in addition to conventional therapy. Meanwhilehile others ...
California blue whales rebound from whaling, first of their kin to do so
2014-09-05
The number of California blue whales has rebounded to near historical levels, according to new research by the University of Washington, and while the number of blue whales struck by ships is likely above allowable U.S. limits, such strikes do not immediately threaten that recovery.
This is the only population of blue whales known to have recovered from whaling – blue whales as a species having been hunted nearly to extinction.
Blue whales – nearly 100 feet in length and weighing 190 tons as adults – are the largest animals on earth. And they are the heaviest ever, weighing ...
Glanville fritillary genome sequenced at the University of Helsinki
2014-09-05
The Glanville fritillary has long been an internationally known model species for ecology and evolutionary biology, whose population biology has been studied on the Åland Islands for more than twenty years. Now the species has become even more significant. Led by Research Professor Ilkka Hanski, the Metapopulation Research Group (MRG) at the University of Helsinki has sequenced the full genome of the Glanville fritillary together with three groups from the Institute of Biotechnology at the same university.
Before the sequencing of the Glanville fritillary genome, which ...
Near-extinct African amphibians 'invisible' under climate change
2014-09-05
An international team of researchers has found that the majority of threatened species are 'invisible' when using modern methods to predict species distributions under climate change.
Using African amphibians as a case study, the researchers found that more than 90 per cent of the species listed as threatened on The IUCN Red List of Threatened Species are omitted by the most popular tools for species distribution modelling.
The study, led by researchers from the Universities of York and Copenhagen and the United Nations Environment Programme World Conservation Monitoring ...
Caffeine therapy for apnea of prematurity does not have long-term harmful effects on sleep
2014-09-05
Caffeine therapy for apnea of prematurity has no long-term harmful effects on sleep or control of breathing, according to a new study of 201 preterm children assessed at ages 5-12, the first study in humans to examine the long-term effects of neonatal caffeine treatment on sleep regulation and ventilatory control.
"Animal studies have suggested that administration of neonatal caffeine to premature infants, while improving survival and other outcomes, may have long-term detrimental effects on sleep and control of breathing during sleep," said lead author Carole L. Marcus, ...
Research finds no association between wearing a bra and breast cancer
2014-09-05
PHILADELPHIA — A population-based case-control study found no association between bra wearing and increased breast cancer risk among postmenopausal women, according to research published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
"There have been some concerns that one of the reasons why breast cancer may be more common in developed countries compared with developing countries is differences in bra-wearing patterns," said Lu Chen, MPH, a researcher in the Public Health Sciences Division at Fred Hutchinson ...
Magnetic nanocubes self-assemble into helical superstructures
2014-09-05
Materials made from nanoparticles hold promise for myriad applications, from improved solar energy production to perfect touch screens. The challenge in creating these wonder-materials is organizing the nanoparticles into orderly arrangements.
Nanoparticles of magnetite, the most abundant magnetic material on earth, are found in living organisms from bacteria to birds. Nanocrystals of magnetite self-assemble into fine compass needles in the organism that help it to navigate.
Collaborating with nanochemists led by Rafal Klajn at the Weizmann Institute of Science in Israel, ...
A lifetime of outdoor activity may contribute to common eye disease; sunglasses may help
2014-09-04
BOSTON (Sept. 4, 2014) — Residential geography, time spent in the sun, and whether or not sunglasses are worn may help explain why some people develop exfoliation syndrome (XFS), an eye condition that is a leading cause of secondary open-angle glaucoma and can lead to an increased risk of cataract and cataract surgery complications, according to a study published on Sept. 4 in JAMA, Ophthalmology.
Despite improvements in understanding the cause of this common yet life-altering condition, more work needs to be done. "The discovery that common genetic variants in the lysyl ...
NASA sees Dolly's remnants bringing showers to the Rio Grande Valley
2014-09-04
Tropical Storm Dolly fizzled out quickly on September 3 after making landfall in eastern Mexico, and NASA's Aqua satellite saw some of the remnants moving into southern Texas. NASA's TRMM satellite analyzed the rainfall occurring in the storm as it was approaching landfall.
NASA's Aqua satellite captured the remnants of Tropical Depression Dolly over northeastern Mexico on Sept. 3 at 19:40 UTC (3:40 p.m. EDT). The image, captured by the Moderate Resolution Imaging Spectroradiometer or MODIS instrument showed the center of Dolly over northeastern Mexico with a band of thunderstorms ...
Hurricane Norbert pinwheels in NASA satellite imagery
2014-09-04
The Eastern Pacific's Hurricane Norbert resembled a pinwheel in an image from NASA's Terra satellite as bands of thunderstorms spiraled into the center. NASA's Global Precipitation Measurement or GPM mission has helped forecasters see that Norbert has lost some of its organization early on September 4.
The MODIS instrument or Moderate Resolution Imaging Spectroradiometer aboard NASA's Terra satellite captured a visible picture of Tropical Storm Norbert on Sept. 4 at 2:15 p.m. EDT when it resembled a pinwheel. The western bands of Norbert were moving over Socorro Island, ...